Filing Details

Accession Number:
0001193805-17-003506
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-11-16 21:32:21
Reporting Period:
2017-11-09
Accepted Time:
2017-11-16 21:32:21
Original Submission Date:
2017-11-13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1708960 Biotest Pharmaceuticals Corp 5800 Park Of Commerce Blvd., Nw
Boca Raton FL 63303
Yes No Yes No
1709152 Ag Biotest Landsteinerstr. 5
Dreieich 2M 63303
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-09 5,813,954 $2.15 10,109,534 No 4 P Indirect By Biotest Pharmaceuticals Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Biotest Pharmaceuticals Corporation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Non-Voting Common Stock 8,591,160 Indirect By Biotest Pharmaceuticals Corporation
Footnotes
  1. Represents a purchase from the underwriters in the issuer's public offering.
  2. The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer.